Regression analysis with femoral artery calcification as the dependent variable
| Model . | Coumarin use beta (95% CI) . | dp-ucMGP beta (95% CI) . |
|---|---|---|
| 1 | 0.515 (0.220-0.809) | 0.661 (0.306-1.016) |
| 2 | 0.484 (0.186-0.782) | 0.623 (0.261-0.985) |
| 3 | 0.443 (0.128-0.758) | 0.584 (0.184-0.984) |
| 4 | 0.510 (0.166-0.854) | 0.725 (0.284-1.165) |
| 5 | 0.509 (0.173-0.846) | 0.680 (0.254-1.105) |
| Model . | Coumarin use beta (95% CI) . | dp-ucMGP beta (95% CI) . |
|---|---|---|
| 1 | 0.515 (0.220-0.809) | 0.661 (0.306-1.016) |
| 2 | 0.484 (0.186-0.782) | 0.623 (0.261-0.985) |
| 3 | 0.443 (0.128-0.758) | 0.584 (0.184-0.984) |
| 4 | 0.510 (0.166-0.854) | 0.725 (0.284-1.165) |
| 5 | 0.509 (0.173-0.846) | 0.680 (0.254-1.105) |
Results are expressed as the beta for coumarin use and dp-ucMGP levels with their 95% confidence interval (CI). Model 1: crude; model 2: adjusted for age; model 3: adjusted for age and sex; model 4: adjusted for age, smoking, body mass index, and triglycerides; model 5: adjusted for age, fasting glucose, LDL cholesterol, estimated creatinine clearance, and calcium phosphate product.